Skip to search formSkip to main contentSkip to account menu

Asthmatic pulmonary eosinophilia

Known as: Eosinophilic asthma, eosinophilia pulmonary, pulmonary eosinophilia 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2019
Review
2019
ABSTRACT Introduction: The last two decades have seen significant progress in the treatment of severe asthma especially the… 
Review
2018
Review
2018
As part of its single technology appraisal (STA) process, the National Institute for Health and Care Excellence (NICE) invited… 
2018
2018
Abstract Introduction: Poorly controlled severe eosinophilic asthma is difficult and costly to manage. Reslizumab, an add-on… 
Review
2016
Review
2016
Difficult asthma is a heterogeneous disease of the airways including various types of bronchial inflammation and various degrees… 
2016
2016
Abstract Objectives: Eosinophilic asthma (EA) is a distinct clinical phenotype characterized by eosinophilic airway inflammation… 
Review
2015
Review
2015
Purpose of reviewThere is considerable evidence that implicates eosinophils as important effector cells in the inflammation… 
Review
2015
Review
2015
Introduction: Patients with severe eosinophilic asthma have an unmet need for novel and efficacious treatments. Reslizumab is one… 
2007
2007
Background Eosinophilic airway inflammation is a key pathophysiological feature of asthma that can predict treatment response… 
2006
2006
STUDY OBJECTIVES It has been suggested that patients with noneosinophilic asthma (NEA) show increased numbers of sputum…